Activity of siRNAs with 2-thio-2'-O-methyluridine modification in mammalian cells

Nucleosides, Nucleotides and Nucleic Acids

Volumn 28, Issue 10, 2009, Pages 902-910

  Prakash, Thazha P ^a   Naik, Nishant ^a   Sioufi, Namir ^a   Bhat, Balkrishen ^a   Swayze, Eric E ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

2' O methyl 2 thiouridine; MRNA expression; Oligonucleotides; SiRNA

Indexed keywords

2 THIO 2' O METHYLURIDINE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; URIDINE DERIVATIVE;

ARTICLE; BIOLOGICAL ACTIVITY; CELL CULTURE; CHEMICAL MODIFICATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; MAMMAL CELL; RNA SYNTHESIS;

CELLS, CULTURED; DRUG DESIGN; HELA CELLS; HUMANS; OLIGONUCLEOTIDES; RNA, SMALL INTERFERING; THIOURIDINE;

MAMMALIA;

EID: 75149169399     PISSN: 15257770     EISSN: 15322335     Source Type: Journal    
DOI: 10.1080/15257770903316145     Document Type: Article

References (31)

1. Fire, A.; Xu, S.; Montgomery, M.K.; Kostas, S.A.; Driver, S.E.; Mello, C.C. Potent and specific interference by double-stranded RNA in Caenorhabditis elegans. Nature, 1998, 391, 806-811. (Pubitemid 28099681)
2. a) Elbashir, S.M.; Harborth, J.; Lendeckel, W.; Yalcin, A.; Weber, K.; Tuschl, T. Duplexes of 21- nucleotide RNAs mediated RNA interference in cultured mammalian cells. Nature, 2001, 411, 494-498.
3. b) Elbashir, S.M.; Lendeckel, W.; Tuschl, T. RNA interference is mediated by 21 and 22 nt RNAs. Genes Dev., 2001, 15, 188-200.
4. c) Caplen, N.J.; Parrish, S.; Imani, F.; Fire, A.; Morgan, R.A. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. USA, 2001, 98, 9742-9747.
5. a) Corey, D.R. RNA learns from antisense. Nature Chem. Biol. 2007, 3, 8-11.
6. b) Bumcrot, D.; Manoharan, M.; Koteliansky, V.; Sah, D.W.Y. RNAi therapeutics: a potential class of pharmaceutical drugs. Nature Chem. Biol. 2006, 2, 711-719.
7. a) Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004, 432, 173-178.
8. b) Sorensen, D.R.; Leirdal, M.; Sioud, M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J. Mol. Biol. 2003, 327, 761-766. (Pubitemid 36315917)
9. c) Lee, N.S.; Dohjima, T.; Bauer, G.; Li, H.; Li, M.J.; Ehsani, A.; Salvaterra, P.; Rossi, J. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 2002, 19, 500-505.
10. d) Jacque, J.M.; Triques, K.; Stevenson, M. Modulation of HIV-1 replication by RNA interference. Nature 2002, 418, 435-438.
11. e) Novinc, C.D.; Murrray, M.F.; Dykxhoorn, D.M.; Beresford, P.J.; Riess, J.; Lee, S.K.; Collman, R.G.; Lieberman, J.; Shankar, P.; Sharp, P. A. siRNA-directed inhibition of HIV-1 infection. Nat. Med. 2002, 8, 681-686.
12. a) Manoharan, M. RNA interference and chemically modified small interfering RNAs. Curr. Opin. Chem. Biol. 2004, 8, 570-579.
13. b) Chiu, Y.L.; Rana, T.M. siRNA function in RNAi: A chemical modification analysis. In RNA, 2003; 9, 1034-1048.
14. a) Allerson, C.R.; Sioufi, N., Jarres, R.; Prakash, T.P.; Naik, N.; Berdeja, A.; Wanders, L.; Griffey, R.H.; et al. Fully 2-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified siRNA. J. Med. Chem. 2005, 48, 901-904.
15. b) Prakash, T.P.; Allerson, C.R.; Dande, P.; Vickers, T.A.; Sioufi, N.; Jarres, R.; Baker, B.F.; Swayze, E.E.; et al. Positional effect of chemical modifications on siRNA activity in mammalian cells. Journal of Medicinal Chemistry 2005, 48, 4247-4253.
16. a) Testa, S.M.; Disney, M.D.; Turner, D.H.; Kierzek, R. Thermodynamics of RNA?RNA duplexes with 2- or 4-thiouridines: implications for antisense design and targeting a group I intron. Biochemistry 1999, 38, 16655-16662.
17. b) Sierzputowska-Gracz, H.; Sochacka, E.; Malkiewicz, A.; Kuo, K.; Gehrke, C.W.; Agris, P.F. Chemistry and structure of modified uridines in the anticodon, wobble position of transfer RNA are determined by thiolation. J. Am. Chem. Soc. 1987, 109, 7171-7177.
18. c) Kawai, G.; Yamamoto, Y.; Kamimura, T.; Masegi, T.; Sekine, M.; Hata, T.; Iimori, T.; Watanabe, T.; Miyazawa, T.; et al. Conformational rigidity of specific pyrimidine residues in tRNA arises from posttranscriptional modifications that enhance steric interaction between the base and the 2-hydroxyl group. Biochemistry 1992, 31, 1040-1046.
19. Kumar, R.K.; Davis, D.R. Synthesis and studies on the effect of 2-thiouridine and 4-thiouridine on sugar conformation and RNA duplex stability. Nucleic Acids Res. 1997, 25, 1272-1280.
20. Kutyavin, I.V.; Rhinehart, R.L.; Lukhtanov, E.A.; Gorn, V.V.; Meyer, R.B., Jr.; Gamper, H.B., Jr. Oligonucleotides containing 2-aminoadenine and 2-thiothymine act as selectively binding complementary agents. Biochemistry 1996, 35, 11170-11176.
21. Shohda, K-i.; Okamoto, I.; Wada, T.; Seio, K.; Sekine, M. Synthesis and Properties of 2- -O-methyl-2- thiouridine and oligonucleotides containing 2-O-methyl-2-thiouridine. Bioorg. Med. Chem. Lett. 2000, 10, 1795-1798.
22. Rajeev, K.G.; Prakash, T.P.; Lesnik, E.A.; Manoharan, M. Synthesis and Properties of 2-modified-2- thiothymidine oligonucleotides. Org. Lett. 2003, 5, 2017-2020.
23. a) Kariko, K.; Buckstein, M.; Ni, H.; Weissman, D. Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 2005, 23, 165-175.
24. b) Rao, S.N.; Bevilacqua, P.C. Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure-specific manner. RNA 2008, 14, 1201-1213.
25. Vickers, T.A.; Koo, S.; Bennett, C.F.; Crooke, S.T.; Dean, N.M.; Baker, B.F. Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. J. Biol. Chem., 2003, 278, 7108-7118.
26. Guzaev, A.P.; Manoharan, M. A conformationally preorganized universal solid support for efficient oligonucleotide synthesis. J. Am. Chem. Soc., 2003, 125, 2380-2381.
27. Wang, Z.; Olsen, P.; Ravikumar, V.T. A novel universal linker for efficient synthesis of phosphorothioate oligonucleotides. Nucleosides, Nucleotides Nucleic Acids 2007, 26, 259-269.
28. Cheruvallath, Z.S.; Carty, R.L.; Moore, M.N.; Capaldi, D.C.; Krotz, A.H. et al. Synthesis of antisense oligonucleotides: replacement of 3H-1,2-benzodithiol-3-one 1,1-dioxide (Beaucage Reagent) with phenylacetyl disulfide (PADS) as efficient sulfurization reagent: from bench to bulk manufacture of active pharmaceutical ingredient. Organic Process Research & Development 2000, 4, 199-204.
29. Gibson, U.E.; Heid, C.A.; Williams, P.M. A novel method for real time quantitative RT-PCR. Genome Res. 1996, 6, 995-1001.
30. Winer, J.; Jung, C.K.; Shackel, I.; Williams, P.M. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal. Biochem. 1999, 270, 41-49.
31. Hashimoto, J.G.; Beadles-bohling, A.S.; Wiren, K.M. Comparison of RiboGreen and 18S rRNA quantification for normalizing real-time RT-PCR expression analysis. BioTechniques 2004, 36, 54-60.